Skip to main content
. Author manuscript; available in PMC: 2018 Oct 5.
Published in final edited form as: Leukemia. 2018 Mar 22;32(10):2250–2262. doi: 10.1038/s41375-018-0104-2

Fig. 6. Synergistic effect of anti-MALAT1 and bortezomib in MM.

Fig. 6

H929(A), MM.1S(B) and RPMI8226(C) cells were transfected with 1nM anti-MALAT1 or control oligos and treated with bortezomib. Cells were collected for immunoblotting, apoptosis assay and qRT-PCR. Cell viability was measured and IC50 was calculated before and after MALAT1 knockdown.( *p<0.05, **p<0.01, ***p<0.001)